Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Standard vs Double Dose Amoxicillin for Non-Severe Pneumonia in Children
NCT00130013Phase 2Completed
- Sponsor
- ARI Research Cell
- Start
- Sep 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of amoxicillin in pneumonia (2 arms), sponsored by ARI Research Cell. Primary endpoint: Proportion of children achieving clinical resolution at Day 5. Started Sep 2003; status: completed.
02
Drugs
amoxicillin
03
Conditions
pneumonia
Beyond the preview
Go deeper on NCT00130013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00130013.